Biomimetic Particles in Drug and Vaccine Delivery

References

• Al-Jamal W. T., Kostarelos K. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine 2007; 2: 85–98
   PubMed Web of Science ®Google Scholar
• Attwood D., Florence A. T. Surfactant Systems:Their Chemistry, Pharmacy and Biology. Chapmann and Hall, New York 1983; 1–772
   Google Scholar
• Bangham A. D. Liposome Letters. Academic Press, London 1983; 1–405
   Google Scholar
• Carmona-Ribeiro A. M. Synthetic amphiphile vesicles. Chem. Soc. Rev. 1992; 21: 209–214
   Web of Science ®Google Scholar
• Carmona-Ribeiro A. M. Bilayer vesicles and liposomes as interface agents. Chem. Soc. Rev. 2001; 30: 241–247
   Web of Science ®Google Scholar
• Carmona-Ribeiro A. M. Bilayer-forming synthetic lipids: drugs or carriers?. Curr. Med. Chem. 2003; 10: 2425–2446
   PubMed Web of Science ®Google Scholar
• Carmona-Ribeiro A. M. Lipid bilayer fragments and disks in drug delivery. Curr. Med. Chem. 2006; 13: 1359–1370
   PubMed Web of Science ®Google Scholar
• Carmona-Ribeiro A. M., Midmore B. R. Synthetic bilayer adsorption onto polystyrene microspheres. Langmuir 1992; 8: 801–806
   Web of Science ®Google Scholar
• Carmona-Ribeiro A. M., Vieira D. B., Lincopan N. Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents Med. Chem. 2006; 5: 33–54
   Google Scholar
• Foged C., Brodin B., Frokjaer S., Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 2005; 298: 315–322
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Bacon A., McCormack B., Laing P. Genetic vaccines: a role for liposomes. Nanopartic. Drug Carriers 2006; 43–55
   Google Scholar
• Gregoriadis G., McCormack B., Obrenovic M., Perrie Y., Saffie R. Liposomes as immunological adjuvants and vaccine carriers. Meth. Mol. Med. 2000; 42: 137–150, (Vaccine Adjuvants)
   Google Scholar
• Hammarstroem L., Velikian I., Karlsson G., Edwards K. Cryo-TEM evidence: sonication of dihexadecyl phosphate does not produce closed bilayers with smooth curvature. Langmuir 1995; 11: 408–410
   Google Scholar
• Honeywell-Nguyen P. L., Bouwstra J. A. Vesicles as a tool for dermal and transdermal delivery. Drugs Pharma. Sci. 2006; 158: 563–585
   Google Scholar
• Johansson E., Engvall C., Arfvidsson M., Lundahl P., Edwards K. Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes. Biophys. Chem. 2005; 113: 183–192
   PubMed Web of Science ®Google Scholar
• Katagiri K., Hashizume M., Kikuchi J. -I., Taketani Y., Murakami M. Creation of asymmetric bilayer membrane on monodispersed colloidal silica particles. Colloids and Surfaces, B: Biointerfaces 2004; 38: 149–153
   PubMedGoogle Scholar
• Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K. L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 4942–4946
   PubMed Web of Science ®Google Scholar
• Lincopan N., Carmona-Ribeiro A. M. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole. J. Antimicrob. Chemother. 2006; 58: 66–75
   PubMedGoogle Scholar
• Lincopan N., Espíndola N. M., Vaz A. J., Carmona-Ribeiro A. M. Cationic supported lipid bilayers for antigen presentation. Int. J. Pharm. 2007; 340(1–2)216–222
   PubMed Web of Science ®Google Scholar
• Lincopan N., Mamizuka E. M., Carmona-Ribeiro A. M. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. J. Antimicrob. Chemother. 2003; 52: 412–418
   PubMedGoogle Scholar
• Lincopan N., Mamizuka E. M., Carmona-Ribeiro A. M. Low Nephrotoxicity of an Effective Amphotericin B Formulation with Cationic Bilayer Fragments. J. Antimicrob. Chemoth. 2005; 55: 727–734
   PubMed Web of Science ®Google Scholar
• Lincopan N., Rosa H., Carmona-Ribeiro A. M. Biomimetic particles. Macromol. Symp. 2006; 245-6: 485–490
   Google Scholar
• Moura S. P., Carmona-Ribeiro A. M. biomimetic particles: optimization of phospholipid bilayer coverage on silica and colloid stabilization. Langmuir 2005; 21: 10160–10164
   PubMedGoogle Scholar
• Moura S. P., Carmona-Ribeiro A. M. Biomimetic particles for isolation and reconstitution of receptor function. Cell Biochem. Biophys. 2006; 44: 446–452
   PubMedGoogle Scholar
• Nath A., Atkins W. M., Sligar S. G. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry 2007; 46: 2059–2069
   PubMed Web of Science ®Google Scholar
• New R. R. C. Liposomes: a Practical Approach. Oxford University Press, Oxford 1990
   Google Scholar
• Pansu R. B., Arrio B., Roncin J., Faure J. Vesicles versus membrane fragments in DODAC suspensions. J. Phys. Chem. 1990; 94: 796–801
   Web of Science ®Google Scholar
• Pacheco L. F., Carmona-Ribeiro A. M. Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. J. Colloid Interface Sci. 2003; 258: 146–154
   PubMedGoogle Scholar
• Pereira E. M. A., Petri D. F. S., Carmona-Ribeiro A. M. Adsorption of cationic lipid bilayer onto flat silicon wafers: effect of ion nature and concentration. J. Phys. Chem. B 2006; 110: 10070–10074
   PubMedGoogle Scholar
• Pereira E. M. A., Vieira D. B., Carmona-Ribeiro A. M. Cationic bilayers on polymeric particles: effect of low NaCl concentration on surface coverage. J. Phys. Chem. B 2004; 108: 11490–11495
   Web of Science ®Google Scholar
• Petri D. F. S., Carmona-Ribeiro A. M. Biomimetic particles. Polymeric Nanostructures and Their Applications, H. S. Nalwa. American Scientific Publishers, Stevenson Ranch 2007; 485–530
   Google Scholar
• Pichot C. Surface-functionalized latexes for biotechnological applications. Curr. Op. Coll. Interf. Sci. 2004; 9: 213–221
   Web of Science ®Google Scholar
• Rapuano R., Carmona-Ribeiro A. M. Supported bilayers on silica. J. Colloid Interface Sci. 2000; 226: 299–307
   Web of Science ®Google Scholar
• Torchilin V. P. Recent advances with liposomes as pharmaceutical carriers. Natl. Rev. Drug Discover. 2005; 4: 145–160
   PubMed Web of Science ®Google Scholar
• Troutier A.-L., Delair T., Pichot C., Ladaviere C. Physicochemical and interfacial investigation of lipid/polymer particle assemblies. Langmuir 2005; 21: 1305–1313
   PubMed Web of Science ®Google Scholar
• Urban M. W., Lestage D. Colloidal particle morphology and film formation; the role of bio-active components on stimuli-responsive behavior. Polymer Rev. 2006; 46: 445–466
   Google Scholar
• Vidard L., Kovacsovics-Bankowski M., Kraeft S. K., Chen L. B., Benacerraf B., Rock K. L. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J. Immunol. 1996; 156: 2809–2818
   PubMed Web of Science ®Google Scholar
• Vieira D. B., Carmona-Ribeiro A. M. Synthetic bilayer fragments for solubilization of amphotericin B. J. Colloid Interface Sci. 2001; 244: 427–431
   Web of Science ®Google Scholar
• Vieira D. B., Carmona-Ribeiro A. M. Cationic lipids and surfactants as anti-fungal agents: mode of action. J. Antimicrob. Chemother. 2006; 58: 760–767
   PubMed Web of Science ®Google Scholar
• Vieira D. B., Pacheco L. F., Carmona-Ribeiro A. M. Assembly of a model hydrophobic drug into cationic bilayer fragments. J. Colloid Interface Sci. 2006; 293: 240–247
   PubMedGoogle Scholar